4.6 Article

Hormone Replacement Therapy, Likely Neither Angel Nor Demon

Related references

Note: Only part of the references are listed.
Article Oncology

Use of tamoxifen and raloxifene for breast cancer chemoprevention in 2010

Erika A. Waters et al.

BREAST CANCER RESEARCH AND TREATMENT (2012)

Editorial Material Oncology

Oestrogen and breast cancer: results from the WHI trial

Anthony Howell et al.

LANCET ONCOLOGY (2012)

Article Medicine, General & Internal

Health Outcomes After Stopping Conjugated Equine Estrogens Among Postmenopausal Women With Prior Hysterectomy A Randomized Controlled Trial

Andrea Z. LaCroix et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)

Article Medicine, General & Internal

Exemestane for Breast-Cancer Prevention in Postmenopausal Women

Paul E. Goss et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Article Oncology

Prevalence of Tamoxifen Use for Breast Cancer Chemoprevention Among US Women

Erika A. Waters et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)

Article Medicine, General & Internal

The decrease in breast-cancer incidence in 2003 in the United States.

Peter M. Ravdin et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)

Review Medicine, General & Internal

Male breast cancer

IS Fentiman et al.

LANCET (2006)

Article Medicine, General & Internal

Influence of estrogen plus progestin on breast, cancer and mammography in healthy postmenopausal women - The Women's Health Initiative Randomized trial

RT Chlebowski et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)

Article Pathology

Genetic relation of lobular carcinoma in situ, ductal carcinoma in situ, and associated invasive carcinoma of the breast

H Buerger et al.

JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY (2000)